These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 29672930)

  • 1. Clinical and imaging correlates of amyloid deposition in dementia with Lewy bodies.
    Donaghy PC; Firbank MJ; Thomas AJ; Lloyd J; Petrides G; Barnett N; Olsen K; O'Brien JT
    Mov Disord; 2018 Jul; 33(7):1130-1138. PubMed ID: 29672930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinct patterns of amyloid-dependent tau accumulation in Lewy body diseases.
    Lee SH; Cho H; Choi JY; Lee JH; Ryu YH; Lee MS; Lyoo CH
    Mov Disord; 2018 Feb; 33(2):262-272. PubMed ID: 29168583
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diffusion imaging in dementia with Lewy bodies: Associations with amyloid burden, atrophy, vascular factors and clinical features.
    Donaghy PC; Firbank M; Petrides G; Lloyd J; Barnett N; Olsen K; Thomas AJ; O'Brien JT
    Parkinsonism Relat Disord; 2020 Sep; 78():109-115. PubMed ID: 32814228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amyloid-β deposition and regional grey matter atrophy rates in dementia with Lewy bodies.
    Sarro L; Senjem ML; Lundt ES; Przybelski SA; Lesnick TG; Graff-Radford J; Boeve BF; Lowe VJ; Ferman TJ; Knopman DS; Comi G; Filippi M; Petersen RC; Jack CR; Kantarci K
    Brain; 2016 Oct; 139(Pt 10):2740-2750. PubMed ID: 27452602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AV-1451 tau and β-amyloid positron emission tomography imaging in dementia with Lewy bodies.
    Kantarci K; Lowe VJ; Boeve BF; Senjem ML; Tosakulwong N; Lesnick TG; Spychalla AJ; Gunter JL; Fields JA; Graff-Radford J; Ferman TJ; Jones DT; Murray ME; Knopman DS; Jack CR; Petersen RC
    Ann Neurol; 2017 Jan; 81(1):58-67. PubMed ID: 27863444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amyloid imaging of Lewy body-associated disorders.
    Foster ER; Campbell MC; Burack MA; Hartlein J; Flores HP; Cairns NJ; Hershey T; Perlmutter JS
    Mov Disord; 2010 Nov; 25(15):2516-23. PubMed ID: 20922808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Imaging characteristic of dual-phase (18)F-florbetapir (AV-45/Amyvid) PET for the concomitant detection of perfusion deficits and beta-amyloid deposition in Alzheimer's disease and mild cognitive impairment.
    Lin KJ; Hsiao IT; Hsu JL; Huang CC; Huang KL; Hsieh CJ; Wey SP; Yen TC
    Eur J Nucl Med Mol Imaging; 2016 Jul; 43(7):1304-14. PubMed ID: 27003417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinicopathological Correlation: Dopamine and Amyloid PET Imaging with Neuropathology in Three Subjects Clinically Diagnosed with Alzheimer's Disease or Dementia with Lewy Bodies.
    Gupta HV; Beach TG; Mehta SH; Shill HA; Driver-Dunckley E; Sabbagh MN; Belden CM; Liebsack C; Dugger BN; Serrano GE; Sue LI; Siderowf A; Pontecorvo MJ; Mintun MA; Joshi AD; Adler CH
    J Alzheimers Dis; 2021; 80(4):1603-1612. PubMed ID: 33720879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential Vulnerability of Hippocampal Subfields to Amyloid and Tau Deposition in the Lewy Body Diseases.
    Ye R; Goodheart AE; Locascio JJ; Peterec E; Properzi M; Thibault EG; Chuba E; Johnson KA; Brickhouse MJ; Touroutoglou A; Growdon JH; Dickerson BC; Gomperts SN
    Neurology; 2024 Jun; 102(12):e209460. PubMed ID: 38815233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. β-Amyloid in Lewy body disease is related to Alzheimer's disease-like atrophy.
    Shimada H; Shinotoh H; Hirano S; Miyoshi M; Sato K; Tanaka N; Ota T; Fukushi K; Irie T; Ito H; Higuchi M; Kuwabara S; Suhara T
    Mov Disord; 2013 Feb; 28(2):169-75. PubMed ID: 23225334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PET imaging of amyloid with Florbetapir F 18 and PET imaging of dopamine degeneration with 18F-AV-133 (florbenazine) in patients with Alzheimer's disease and Lewy body disorders.
    Siderowf A; Pontecorvo MJ; Shill HA; Mintun MA; Arora A; Joshi AD; Lu M; Adler CH; Galasko D; Liebsack C; Skovronsky DM; Sabbagh MN
    BMC Neurol; 2014 Apr; 14():79. PubMed ID: 24716655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between amyloid-beta deposition and cortical thickness in dementia with Lewy bodies.
    Chin KS; Gajamange S; Desmond PM; Villemagne VL; Rowe CC; Churilov L; Yassi N; Watson R
    Aust N Z J Psychiatry; 2023 Apr; 57(4):594-602. PubMed ID: 35196886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. α-Synuclein species as potential cerebrospinal fluid biomarkers for dementia with lewy bodies.
    van Steenoven I; Majbour NK; Vaikath NN; Berendse HW; van der Flier WM; van de Berg WDJ; Teunissen CE; Lemstra AW; El-Agnaf OMA
    Mov Disord; 2018 Nov; 33(11):1724-1733. PubMed ID: 30440090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imaging amyloid deposition in Lewy body diseases.
    Gomperts SN; Rentz DM; Moran E; Becker JA; Locascio JJ; Klunk WE; Mathis CA; Elmaleh DR; Shoup T; Fischman AJ; Hyman BT; Growdon JH; Johnson KA
    Neurology; 2008 Sep; 71(12):903-10. PubMed ID: 18794492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microbleeds in dementia with Lewy bodies.
    Donaghy PC; Firbank M; Mitra D; Petrides G; Lloyd J; Barnett N; Olsen K; Thomas AJ; O'Brien JT
    J Neurol; 2020 May; 267(5):1491-1498. PubMed ID: 32016624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Imaging and acetylcholinesterase inhibitor response in dementia with Lewy bodies.
    Graff-Radford J; Boeve BF; Pedraza O; Ferman TJ; Przybelski S; Lesnick TG; Vemuri P; Senjem ML; Smith GE; Knopman DS; Lowe V; Jack CR; Petersen RC; Kantarci K
    Brain; 2012 Aug; 135(Pt 8):2470-7. PubMed ID: 22810436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amyloid Imaging and Longitudinal Clinical Progression in Dementia With Lewy Bodies.
    Donaghy PC; Firbank MJ; Thomas AJ; Lloyd J; Petrides G; Barnett N; Olsen K; O'Brien JT
    Am J Geriatr Psychiatry; 2020 May; 28(5):573-577. PubMed ID: 31953009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beta amyloid deposition maps onto hippocampal and subiculum atrophy in dementia with Lewy bodies.
    Mak E; Donaghy PC; McKiernan E; Firbank MJ; Lloyd J; Petrides GS; Thomas AJ; O'Brien JT
    Neurobiol Aging; 2019 Jan; 73():74-81. PubMed ID: 30339962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PET imaging of brain amyloid in dementia: a review.
    Quigley H; Colloby SJ; O'Brien JT
    Int J Geriatr Psychiatry; 2011 Oct; 26(10):991-9. PubMed ID: 21905095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroimaging of Inflammation in Memory and Related Other Disorders (NIMROD) study protocol: a deep phenotyping cohort study of the role of brain inflammation in dementia, depression and other neurological illnesses.
    Bevan-Jones WR; Surendranathan A; Passamonti L; Vázquez Rodríguez P; Arnold R; Mak E; Su L; Coles JP; Fryer TD; Hong YT; Williams G; Aigbirhio F; Rowe JB; O'Brien JT
    BMJ Open; 2017 Jan; 7(1):e013187. PubMed ID: 28064175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.